1. Home
  2. OCS vs PTA Comparison

OCS vs PTA Comparison

Compare OCS & PTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCS
  • PTA
  • Stock Information
  • Founded
  • OCS 2003
  • PTA 2020
  • Country
  • OCS Switzerland
  • PTA United States
  • Employees
  • OCS N/A
  • PTA N/A
  • Industry
  • OCS Biotechnology: Pharmaceutical Preparations
  • PTA Trusts Except Educational Religious and Charitable
  • Sector
  • OCS Health Care
  • PTA Finance
  • Exchange
  • OCS Nasdaq
  • PTA Nasdaq
  • Market Cap
  • OCS 1.0B
  • PTA 1.1B
  • IPO Year
  • OCS N/A
  • PTA N/A
  • Fundamental
  • Price
  • OCS $19.00
  • PTA $20.07
  • Analyst Decision
  • OCS Strong Buy
  • PTA
  • Analyst Count
  • OCS 3
  • PTA 0
  • Target Price
  • OCS $35.33
  • PTA N/A
  • AVG Volume (30 Days)
  • OCS 27.1K
  • PTA 159.2K
  • Earning Date
  • OCS 08-26-2025
  • PTA 01-01-0001
  • Dividend Yield
  • OCS N/A
  • PTA 8.31%
  • EPS Growth
  • OCS N/A
  • PTA N/A
  • EPS
  • OCS N/A
  • PTA N/A
  • Revenue
  • OCS $847,333.00
  • PTA N/A
  • Revenue This Year
  • OCS $18.70
  • PTA N/A
  • Revenue Next Year
  • OCS $1,059.78
  • PTA N/A
  • P/E Ratio
  • OCS N/A
  • PTA N/A
  • Revenue Growth
  • OCS N/A
  • PTA N/A
  • 52 Week Low
  • OCS $10.79
  • PTA $15.84
  • 52 Week High
  • OCS $23.08
  • PTA $19.67
  • Technical
  • Relative Strength Index (RSI)
  • OCS 46.89
  • PTA 68.11
  • Support Level
  • OCS $18.87
  • PTA $19.62
  • Resistance Level
  • OCS $19.75
  • PTA $19.86
  • Average True Range (ATR)
  • OCS 0.43
  • PTA 0.18
  • MACD
  • OCS -0.11
  • PTA 0.03
  • Stochastic Oscillator
  • OCS 32.43
  • PTA 92.90

About OCS Oculis Holding AG Ordinary shares

Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.

About PTA Cohen & Steers Tax-Advantaged Preferred Securities and Income Fund of Beneficial Interest

COHEN & STEERS TAX-ADV PRD SEC AND INC is a non-diversified, closed-end management statutory trust. Its primary investment objective is high current income, and the Fund's secondary investment objective is capital appreciation.

Share on Social Networks: